Zhaohui Liao Arter

15PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Women's studies (incl. girls' studies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 04, 2026
Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available - Practical Dose Selection Considerations and Real-World Access Challenges.

|May 20, 2026
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case Report.

|Jan 01, 2026
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report.

Alexandria T M Lee, Cathleen June Park, Zhaohui Liao Arter

|Oct 29, 2025
Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib.

Sai-Hong Ignatius Ou, Cathleen June Park, Zhaohui Liao Arter

|Jun 20, 2025
Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data.

Zhaohui Liao Arter, David J Benjamin, Yen Cao

|Jun 19, 2025
Emotional distress: the hidden barrier to immunotherapy success in advanced non-small cell lung cancer.

Shannon Zhang, Shiyao Wang, Zhaohui Liao Arter

Pageof 3

Frequent Collaborators

8 joint publications

Misako Nagasaka

6 joint publications

Sai-Hong Ignatius Ou

3 joint publications

Cathleen June Park

1 joint publications

Gianna Kroening